Pro-Life Leaders Urge FDA Nominee to Reinstate Safety Standards for Abortion Drug

Faith Facts

• Fifty pro-life leaders, including pastors, issued a joint statement urging the FDA nominee to restore safety standards on mifepristone.
• The leaders emphasize protecting the unborn and upholding traditional family values in public policy.
• The statement calls for a thorough safety review before any further regulatory decisions on the abortion drug.

A coalition of 50 pro-life leaders, including pastors, released a joint statement on Thursday calling on FDA Commissioner nominee Dr. Heidi Overton to restore earlier safeguards on the abortion drug mifepristone while the agency finishes a long-running safety review.

“We urge Dr. Overton to prioritize the health and safety of women and the protection of unborn life by reinstating the minimal safeguards that were previously in place,”

The leaders’ statement highlights the importance of restoring safeguards that were removed in recent years.

“The FDA has a responsibility to ensure that all medications, especially those used to end unborn lives, meet the highest standards of safety and oversight,”

Let us know what you think, please share your thoughts in the comments below.